We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.9B
1-Year Est. Return 23.65%
This Fund
S&P 500
This Quarter Est. Return
+6.34%
1 Year Est. Return
+23.65%
3 Year Est. Return
+66.72%
5 Year Est. Return
+71.27%
10 Year Est. Return
+298.51%
AUM
$2.62B
AUM Growth
+$368M
Cap. Flow
+$229M
Cap. Flow %
8.75%
Top 10 Hldgs %
18.1%
Holding
2,638
New
585
Increased
1,008
Reduced
426
Closed
81

Sector Composition

Rank Sector Weight
1 Technology 8.21%
2 Financials 4.98%
3 Healthcare 4.3%
4 Consumer Discretionary 3.17%
5 Industrials 3.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBHY icon
1601
JPMorgan BetaBuilders USD High Yield Corporate Bond ETF
BBHY
$618M
$17.8K ﹤0.01%
375
-16
-4% -$744
BWA icon
1602
BorgWarner
BWA
$13.9B
$17.6K ﹤0.01%
486
+153
+46% +$5.04K
EXPD icon
1603
Expeditors International
EXPD
$23.2B
$17.6K ﹤0.01%
134
-547
-80% -$67K
FNDE icon
1604
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$9.81B
$17.6K ﹤0.01%
544
-71,780
-99% -$2.15M
FLC
1605
Flaherty & Crumrine Total Return Fund
FLC
$175M
$17.5K ﹤0.01%
1,015
VLU icon
1606
State Street SPDR S&P 1500 Value Tilt ETF
VLU
$771M
$17.5K ﹤0.01%
95
E icon
1607
ENI
E
$77.5B
$17.5K ﹤0.01%
+576
New +$18K
ROAD icon
1608
Construction Partners
ROAD
$6.77B
$17.4K ﹤0.01%
250
CUBE icon
1609
CubeSmart
CUBE
$9.41B
$17.4K ﹤0.01%
324
+24
+8% +$1.19K
PEB icon
1610
Pebblebrook Hotel Trust
PEB
$2.05B
$17.4K ﹤0.01%
1,316
S icon
1611
SentinelOne
S
$7.34B
$17.3K ﹤0.01%
725
BDC icon
1612
Belden
BDC
$5.19B
$17.3K ﹤0.01%
148
+41
+38% +$4.11K
ZTR
1613
Virtus Total Return Fund
ZTR
$339M
$17.2K ﹤0.01%
2,770
+1,625
+142% +$9.44K
CRI icon
1614
Carter's
CRI
$1.47B
$17.2K ﹤0.01%
264
+8
+3% +$514
ARLP icon
1615
Alliance Resource Partners
ARLP
$3.17B
$17.1K ﹤0.01%
685
-600
-47% -$14.5K
FXA icon
1616
Invesco CurrencyShares Australian Dollar Trust
FXA
$98M
$17.1K ﹤0.01%
250
FXD icon
1617
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$276M
$17.1K ﹤0.01%
270
SKT icon
1618
Tanger
SKT
$4.52B
$17.1K ﹤0.01%
515
+15
+3% +$438
NVMI
1619
Nova
NVMI
$12.5B
$17.1K ﹤0.01%
+82
New +$17.5K
FOXF icon
1620
Fox Factory Holding Corp
FOXF
$886M
$17K ﹤0.01%
410
+30
+8% +$1.3K
TOL icon
1621
Toll Brothers
TOL
$14.5B
$17K ﹤0.01%
110
+10
+10% +$1.36K
CHX
1622
DELISTED
ChampionX
CHX
$16.9K ﹤0.01%
561
+309
+123% +$9.76K
MORN icon
1623
Morningstar
MORN
$7.53B
$16.9K ﹤0.01%
+53
New +$16.5K
EMN icon
1624
Eastman Chemical
EMN
$8.42B
$16.9K ﹤0.01%
151
+141
+1,410% +$14.1K
EMGF icon
1625
iShares Emerging Markets Equity Factor ETF
EMGF
$1.87B
$16.9K ﹤0.01%
339
+139
+70% +$6.53K

Similar funds

Geneos Wealth Management's Q3 2024 Portfolio in Review

As of Q3 2024, Geneos Wealth Management held 2,638 positions worth $2.62B, up 16% from $2.25B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Geneos Wealth Management deployed $229M of net new capital in Q3 2024, opening 585 new positions and adding to 1,008 existing holdings. Its largest new stake was iShares Core MSCI International Developed Markets ETF: 104,319 shares worth $7.39M.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, down from 8.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $11.9M trimmed.

  • Geneos Wealth Management's largest Q3 2024 buy was iShares Core MSCI International Developed Markets ETF: 104,319 shares worth $7.39M.
  • Geneos Wealth Management added most to PGIM Ultra Short Bond ETF in Q3 2024, an estimated $9.4M increase.
  • Geneos Wealth Management's biggest Q3 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $11.9M.
  • Geneos Wealth Management fully exited iShares MSCI Germany ETF in Q3 2024, selling an estimated $2.37M.
  • Geneos Wealth Management's ten largest holdings make up 18% of its $2.62B portfolio in Q3 2024.
  • Geneos Wealth Management opened 585 new positions and closed 81 in Q3 2024.
  • Geneos Wealth Management's portfolio value rose 16% quarter-over-quarter to $2.62B.

Based on Geneos Wealth Management's 13F filing for Q3 2024, filed 14 Nov 2024.